Related Experiment Videos
Bladder wash flow cytometry in transitional cell carcinoma: useful or misleading?
1Department of Pathology, Hospital Clínic i Provincial, University of Barcelona, Spain.
Urological Research
|January 1, 1995
Summary
Flow cytometry (FC) shows limited use for diagnosing bladder transitional cell carcinoma (TCC) initially. However, FC is a valuable tool for monitoring patients with a history of TCC, improving diagnostic accuracy alongside cytology.
Area of Science:
- Urology
- Oncology
- Diagnostic Cytology
Background:
- Transitional cell carcinoma (TCC) is a common malignancy of the urinary bladder.
- Accurate diagnosis and monitoring of TCC are crucial for patient outcomes.
- Flow cytometry (FC) and conventional cytology are diagnostic methods for TCC.
Purpose of the Study:
- To assess the clinical utility of flow cytometry (FC) in diagnosing transitional cell carcinoma (TCC) from bladder wash specimens.
- To compare the diagnostic performance of FC with conventional cytology.
- To evaluate the combined diagnostic efficacy of FC and cytology.
Main Methods:
- A study involving 101 cases: 60 with TCC (current or history) and 41 controls.
- Analysis of bladder wash specimens using flow cytometry (FC) and conventional cytology.
- Comparison of diagnostic accuracy metrics including sensitivity, specificity, and predictive values.
Main Results:
- FC demonstrated low specificity (54%) and positive predictive value (58%) for initial TCC diagnosis compared to controls.
- Conventional cytology outperformed FC in the general diagnostic setting.
- For patients with a history of TCC, FC showed superior performance to cytology, with combined techniques yielding high sensitivity (94%) and negative predictive value (93%).
Conclusions:
- Flow cytometry (FC) use in a general diagnostic setting for TCC may be misleading.
- FC serves as a useful adjunct to cytology in the follow-up of patients with a history of TCC.
- The combination of FC and cytology enhances diagnostic performance, potentially allowing for spaced-out cystoscopies in follow-up patients.